What is Option Care Health's operating income?

Option Care Health's total operating income in 2025 was $337.91 million, based on the following breakdown: Total Gross Profit: $1.09 billion Total Operating Expenses: $749.99 million

Option Care Health (OPCH) Financials

$23.03 +0.57 (+2.54%)

Closing price 07/31/2026 04:00 PM Eastern

Extended Trading

$22.91 -0.12 (-0.53%)

As of 07/31/2026 07:34 PM Eastern

Compare

Annual Income Statements for Option Care Health

This table shows Option Care Health's income and expenses over time, based on annual financial data. All values are USD millions unless otherwise specified.

Metric	2015	2016	2017	2018	2019	2020	2021	2022	2023	2024	2025
Period end date	12/31/2015	12/31/2016	12/31/2017	12/31/2018	12/31/2019	12/31/2020	12/31/2021	12/31/2022	12/31/2023	12/31/2024	12/31/2025
Net Income / (Loss) Attributable to Common Shareholders	-310	-52	3.88	-6.12	-76	-8.08	140	172	261	208	201
Consolidated Net Income / (Loss)	-300	-43	3.88	-6.12	-76	-8.08	140	151	267	212	208
Net Income / (Loss) Continuing Operations	-305	-36	3.88	-6.12	-76	-8.08	140	151	267	212	208
Total Pre-Tax Income	-326	-34	-15	-8.77	-78	-5.24	116	206	359	284	283
Total Operating Income	-247	-11	27	38	-0.32	111	191	240	315	322	338
Total Gross Profit	260	262	446	422	513	682	780	867	981	1,013	1,088
Total Revenue	982	936	1,828	1,940	2,310	3,033	3,439	3,945	4,302	4,998	5,650
Operating Revenue	982	936	1,828	1,940	2,310	3,033	3,439	3,945	4,302	4,998	5,650
Total Cost of Revenue	722	700	1,382	1,518	1,797	2,350	2,659	3,078	3,321	3,985	4,562
Operating Cost of Revenue	722	674	1,382	1,518	1,797	2,350	2,659	3,078	3,321	3,985	4,562
Total Operating Expenses	507	246	419	384	513	572	589	627	667	691	750
Selling, General & Admin Expense	208	209	338	346	460	500	526	566	607	630	682
Depreciation Expense	23	22	35	38	54	71	63	61	59	61	68
Total Other Income / (Expense), net	-79	-23	-42	-47	-78	-116	-74	-34	44	-38	-55
Interest Expense	79	0.00	-	46	74	108	67	54	51	49	55
Interest & Investment Income	-	-38	2.19	1.02	2.84	3.31	6.03	5.13	5.53	5.96	7.41
Other Income / (Expense), net	0.00	14	-44	-2.23	-6.99	-12	-13	14	90	4.83	-7.86
Income Tax Expense	-22	2.02	-19	-2.65	-2.27	2.83	-23	55	92	72	75
Other Adjustments to Net Income / (Loss) Attributable to Common Shareholders)	-	-	-	-	-	-	-	-22	6.18	3.93	6.94
Basic Earnings per Share	($4.51)	($0.55)	$0.03	($0.04)	($0.49)	($0.04)	$0.78	$0.83	$1.49	$1.23	$1.28
Weighted Average Basic Shares Outstanding	68.71M	93.74M	142.61M	142.61M	156.28M	180.97M	179.86M	181.11M	178.97M	171.57M	162.10M
Diluted Earnings per Share	($4.51)	($0.55)	$0.03	($0.04)	($0.49)	($0.04)	$0.77	$0.83	$1.48	$1.23	$1.27
Weighted Average Diluted Shares Outstanding	68.71M	93.74M	142.61M	142.61M	156.28M	180.97M	181.21M	182.08M	180.38M	172.85M	163.37M
Weighted Average Basic & Diluted Shares Outstanding	68.71M	93.74M	142.61M	142.61M	156.28M	179.81M	179.94M	181.96M	173.50M	165.32M	156.45M

This table shows Option Care Health's income and expenses over time, based on quarterly financial data. All values are USD millions unless otherwise specified.

Metric	Q4 2023	Q1 2024	Q2 2024	Q3 2024	Q4 2024	Q1 2025	Q2 2025	Q3 2025	Q4 2025	Q1 2026	Q2 2026
Period end date	12/31/2023	3/31/2024	6/30/2024	9/30/2024	12/31/2024	3/31/2025	6/30/2025	9/30/2025	12/31/2025	3/31/2026	6/30/2026
Net Income / (Loss) Attributable to Common Shareholders	51	46	52	48	62	44	49	50	57	45	53
Consolidated Net Income / (Loss)	57	45	53	54	60	47	51	52	59	45	54
Net Income / (Loss) Continuing Operations	57	45	53	54	60	47	51	52	59	45	54
Total Pre-Tax Income	79	57	72	74	81	64	69	69	82	61	74
Total Operating Income	85	69	81	85	87	79	83	85	92	73	85
Total Gross Profit	247	239	249	257	268	263	269	273	283	262	267
Total Revenue	1,124	1,146	1,227	1,279	1,346	1,333	1,416	1,435	1,465	1,351	1,442
Operating Revenue	1,124	1,146	1,227	1,279	1,346	1,333	1,416	1,435	1,465	1,351	1,442
Total Cost of Revenue	877	908	978	1,022	1,078	1,070	1,147	1,162	1,183	1,089	1,175
Operating Cost of Revenue	877	908	978	1,022	1,078	1,070	1,147	1,162	1,183	1,089	1,175
Total Operating Expenses	163	169	169	172	181	184	186	188	191	189	182
Selling, General & Admin Expense	148	155	154	157	165	168	170	172	172	175	165
Depreciation Expense	15	15	15	15	17	16	16	16	19	15	17
Total Other Income / (Expense), net	-5.63	-12	-8.63	-12	-5.99	-16	-14	-16	-9.99	-12	-11
Interest Expense	12	13	13	12	11	13	14	14	13	13	14
Interest & Investment Income	1.42	1.13	1.41	1.39	2.04	1.73	1.40	2.18	2.11	1.69	1.70
Other Income / (Expense), net	5.38	0.00	2.56	-0.58	2.85	-4.13	-0.80	-3.57	0.64	0.07	1.16
Income Tax Expense	22	12	19	20	21	17	18	17	23	16	20
Other Adjustments to Net Income / (Loss) Attributable to Common Shareholders)	-	-1.55	0.90	6.13	-	2.40	1.68	1.46	1.40	0.73	1.14
Basic Earnings per Share	$0.32	$0.26	$0.31	$0.32	$0.34	$0.28	$0.31	$0.32	$0.37	$0.29	$0.35
Weighted Average Basic Shares Outstanding	178.97M	173.93M	172.93M	170.64M	171.57M	165.46M	162.93M	161.83M	162.10M	156.65M	152.93M
Diluted Earnings per Share	$0.33	$0.26	$0.30	$0.31	$0.36	$0.28	$0.31	$0.32	$0.36	$0.29	$0.35
Weighted Average Diluted Shares Outstanding	180.38M	175.62M	174.09M	171.94M	172.85M	166.80M	164.13M	163.09M	163.37M	158.21M	153.49M
Weighted Average Basic & Diluted Shares Outstanding	173.50M	173.82M	171.02M	170.18M	165.32M	163.75M	162.30M	158.73M	156.45M	157.03M	149.79M

This table details how cash moves in and out of Option Care Health's business through operations, investing, and financing, using annual figures. All values are USD millions unless otherwise specified.

Metric	2015	2016	2017	2018	2019	2020	2021	2022	2023	2024	2025
Period end date	12/31/2015	12/31/2016	12/31/2017	12/31/2018	12/31/2019	12/31/2020	12/31/2021	12/31/2022	12/31/2023	12/31/2024	12/31/2025
Net Change in Cash & Equivalents	15	-6.01	8.25	-17	31	32	20	175	50	69	-180
Net Cash From Operating Activities	-64	-43	38	24	39	127	209	268	371	323	258
Net Cash From Continuing Operating Activities	-63	-36	38	24	39	127	209	268	371	323	258
Net Income / (Loss) Continuing Operations	-305	-36	3.88	-6.12	-76	-8.08	140	151	267	212	208
Consolidated Net Income / (Loss)	-300	-43	3.88	-6.12	-76	-8.08	140	151	267	212	208
Depreciation Expense	23	22	38	41	58	78	69	65	62	63	71
Amortization Expense	3.44	4.04	3.00	3.11	4.54	5.52	5.00	4.30	4.45	4.63	4.15
Non-Cash Adjustments To Reconcile Net Income	255	-17	1.46	7.79	25	27	17	6.45	30	34	42
Changes in Operating Assets and Liabilities, net	-39	-8.53	-8.53	-21	28	25	-22	41	7.61	9.82	-66
Net Cash From Investing Activities	13	-73	-24	-37	-728	-26	-112	-108	-57	-36	-161
Net Cash From Continuing Investing Activities	-12	-73	-24	-37	-728	-26	-112	-108	-57	-36	-161
Purchase of Property, Plant & Equipment	-12	-9.87	-25	-26	-28	-27	-26	-35	-42	-36	-41
Acquisitions	0.00	-68	0.00	-11	-700	0.00	-86	-87	-12	0.00	-117
Sale of Property, Plant & Equipment	0.00	4.18	0.48	0.00	0.01	0.00	0.00	15	3.74	0.00	0.00
Other Investing Activities, net	0.00	-	0.00	0.00	0.63	0.54	0.00	0.00	-5.89	-0.86	-2.53
Net Cash From Financing Activities	67	110	-5.15	-4.15	719	-69	-77	15	-265	-218	-277
Net Cash From Continuing Financing Activities	67	110	-5.15	-4.15	719	-69	-77	15	-265	-218	-277
Repayment of Debt	-197	-78	-4.15	-5.15	-261	-187	-932	-6.00	-12	-3.06	-186
Repurchase of Common Equity	-	-	-	-	-	-	0.00	0.00	-250	-253	-310
Issuance of Debt	204	104	0.00	1.00	981	0.00	855	0.00	0.00	50	229
Other Financing Activities, net	-	-0.20	-1.00	0.00	-1.19	-0.90	-0.03	21	-3.12	-12	-11
Cash Interest Paid	34	35	43	47	51	98	61	50	70	72	65
Cash Income Taxes Paid	0.11	-0.37	1.19	1.60	2.41	2.88	5.71	13	75	65	67

This table details how cash moves in and out of Option Care Health's business through operations, investing, and financing, using quarterly figures. All values are USD millions unless otherwise specified.

Metric	Q4 2023	Q1 2024	Q2 2024	Q3 2024	Q4 2024	Q1 2025	Q2 2025	Q3 2025	Q4 2025	Q1 2026	Q2 2026
Period end date	12/31/2023	3/31/2024	6/30/2024	9/30/2024	12/31/2024	3/31/2025	6/30/2025	9/30/2025	12/31/2025	3/31/2026	6/30/2026
Net Change in Cash & Equivalents	-43	-124	157	106	-70	-241	27	111	-77	-55	16
Net Cash From Operating Activities	51	-69	196	160	36	-7.21	90	139	36	-12	184
Net Cash From Continuing Operating Activities	51	-69	196	160	36	-7.21	90	139	36	-12	184
Net Income / (Loss) Continuing Operations	57	45	53	54	60	47	51	52	59	45	54
Consolidated Net Income / (Loss)	57	45	53	54	60	47	51	52	59	45	54
Depreciation Expense	16	15	15	15	17	16	17	17	20	16	18
Amortization Expense	1.13	1.13	1.17	1.16	1.16	1.15	1.17	1.14	0.69	0.68	0.70
Non-Cash Adjustments To Reconcile Net Income	23	10	6.61	9.53	7.24	8.12	12	14	8.45	7.82	19
Changes in Operating Assets and Liabilities, net	-46	-140	119	81	-50	-80	9.76	56	-52	-82	92
Net Cash From Investing Activities	-16	-5.82	-9.78	-9.67	-11	-127	-9.02	-12	-14	-9.32	-12
Net Cash From Continuing Investing Activities	-16	-5.82	-9.78	-9.67	-11	-127	-9.02	-12	-14	-9.32	-12
Purchase of Property, Plant & Equipment	-20	-5.82	-9.78	-9.67	-10	-9.37	-9.10	-9.20	-14	-9.05	-11
Other Investing Activities, net	-	-	-	-	-0.86	0.00	-	-	-	-0.27	-0.60
Net Cash From Financing Activities	-78	-50	-29	-45	-95	-107	-54	-17	-99	-34	-155
Net Cash From Continuing Financing Activities	-78	-50	-29	-45	-95	-107	-54	-17	-99	-34	-155
Repayment of Debt	-1.50	-1.50	-0.41	0.48	-1.63	0.32	-1.15	-184	-1.70	-3.74	-0.77
Other Financing Activities, net	-1.18	-48	-0.00	-3.05	-1.15	-108	100	-0.02	-2.68	-30	16
Cash Interest Paid	23	12	24	13	23	11	22	9.99	22	9.56	21
Cash Income Taxes Paid	22	0.00	32	13	19	0.83	39	10	17	0.27	34

This table presents Option Care Health's assets and liabilities at the end of each period, using annual balance sheet data. All values are USD millions unless otherwise specified.

Metric	2015	2016	2017	2018	2019	2020	2021	2022	2023	2024	2025
Period end date	12/31/2015	12/31/2016	12/31/2017	12/31/2018	12/31/2019	12/31/2020	12/31/2021	12/31/2022	12/31/2023	12/31/2024	12/31/2025
Total Assets	531	605	603	1,428	2,590	2,647	2,791	3,113	3,217	3,422	3,456
Total Current Assets	184	173	187	467	559	657	710	994	1,094	1,323	1,265
Cash & Equivalents	16	9.57	39	36	67	99	119	294	344	413	233
Accounts Receivable	97	109	86	310	324	328	338	378	378	410	474
Inventories, net	43	36	38	83	116	159	183	224	274	388	471
Prepaid Expenses	28	19	19	38	51	71	69	98	99	112	88
Plant, Property, & Equipment, net	32	33	27	93	133	121	112	108	121	127	139
Total Noncurrent Assets	315	399	390	868	1,898	1,869	1,603	2,010	2,002	1,972	2,052
Goodwill	309	366	367	632	1,426	1,429	1,478	1,533	1,540	1,540	1,607
Intangible Assets	5.13	31	19	220	386	23	-	22	20	301	22
Other Noncurrent Operating Assets	1.16	1.99	2.12	15	86	417	99	454	442	130	423
Total Liabilities & Shareholders' Equity	531	605	603	1,428	2,590	2,647	2,791	3,113	3,217	3,422	3,456
Total Liabilities	549	567	606	825	1,683	1,632	1,615	1,727	1,795	2,018	2,129
Total Current Liabilities	153	130	105	240	330	434	460	565	618	780	829
Short-Term Debt	24	19	1.72	4.15	9.25	9.25	6.00	6.00	6.00	6.51	6.78
Accounts Payable	65	64	66	188	221	283	279	379	427	611	640
Accrued Expenses	53	37	26	23	34	64	72	84	75	78	88
Current Employee Benefit Liabilities	-	-	-	25	46	59	84	77	93	63	70
Other Current Liabilities	3.49	3.68	4.62	0.00	20	19	19	19	18	22	24
Total Noncurrent Liabilities	396	436	501	585	1,353	1,198	1,155	1,161	1,177	1,237	1,300
Long-Term Debt	394	433	479	535	1,277	1,115	1,060	1,058	1,057	1,105	1,154
Noncurrent Deferred & Payable Income Tax Liabilities	0.24	2.28	-	33	2.14	3.34	0.00	22	35	48	56
Other Noncurrent Operating Liabilities	1.86	0.76	22	17	73	79	95	81	85	85	90
Total Equity & Noncontrolling Interests	-81	-34	-85	603	907	1,016	1,176	1,386	1,422	1,404	1,326
Total Preferred & Common Equity	-81	-34	-85	603	907	1,016	1,176	1,386	1,422	1,404	1,326
Preferred Stock	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Total Common Equity	-81	-34	-85	603	907	1,016	1,176	1,386	1,422	1,404	1,326
Common Stock	532	612	625	620	1,008	1,129	1,139	1,177	1,204	1,231	1,264
Retained Earnings	-602	-645	-710	-16	-92	-100	40	190	458	669	877
Treasury Stock	-11	0.00	-0.02	0.00	-2.40	-2.40	-2.40	-2.40	-255	-508	-818
Accumulated Other Comprehensive Income / (Loss)	-	-	-	0.84	-7.20	-11	-0.45	21	15	11	4.11

This table presents Option Care Health's assets and liabilities at the end of each period, using quarterly balance sheet data. All values are USD millions unless otherwise specified.

Metric	Q1 2023	Q2 2023	Q3 2023	Q1 2024	Q2 2024	Q3 2024	Q1 2025	Q2 2025	Q3 2025	Q1 2026	Q2 2026
Period end date	3/31/2023	6/30/2023	9/30/2023	3/31/2024	6/30/2024	9/30/2024	3/31/2025	6/30/2025	9/30/2025	3/31/2026	6/30/2026
Total Assets	3,130	3,321	3,244	3,250	3,349	3,428	3,309	3,383	3,480	3,380	3,379
Total Current Assets	1,030	1,198	1,116	1,130	1,227	1,321	1,099	1,175	1,283	1,195	1,201
Cash & Equivalents	298	441	386	220	377	483	171	199	310	177	194
Accounts Receivable	395	397	383	574	468	429	477	481	475	516	512
Inventories, net	250	263	251	242	281	311	369	404	416	416	400
Prepaid Expenses	87	98	95	95	101	99	82	92	83	86	96
Plant, Property, & Equipment, net	106	107	108	121	124	126	131	134	134	140	140
Total Noncurrent Assets	1,640	2,016	2,019	1,999	1,997	1,980	2,078	2,074	2,063	2,045	2,038
Goodwill	1,534	1,541	1,540	1,540	1,540	1,540	1,606	1,606	1,607	1,607	1,607
Intangible Assets	-	22	344	327	318	310	337	24	318	300	291
Other Noncurrent Operating Assets	106	454	135	132	139	131	135	445	138	138	140
Total Liabilities & Shareholders' Equity	3,130	3,321	3,244	3,250	3,349	3,428	3,309	3,383	3,480	3,380	3,379
Total Liabilities	1,780	1,846	1,804	1,820	1,937	2,001	1,958	2,023	2,121	2,029	2,119
Total Current Liabilities	619	668	624	637	695	763	714	774	824	730	819
Short-Term Debt	6.00	6.00	6.00	6.00	6.51	6.51	6.51	6.51	6.78	6.78	6.78
Accounts Payable	449	468	430	486	536	592	529	590	628	545	640
Accrued Expenses	96	103	89	83	69	82	106	81	93	104	84
Current Employee Benefit Liabilities	49	73	81	43	62	61	50	73	72	49	66
Other Current Liabilities	19	19	18	19	22	22	22	23	23	24	23
Total Noncurrent Liabilities	1,162	1,177	1,179	1,183	1,242	1,238	1,244	1,249	1,297	1,299	1,299
Long-Term Debt	1,058	1,057	1,057	1,056	1,106	1,105	1,104	1,104	1,155	1,153	1,152
Noncurrent Deferred & Payable Income Tax Liabilities	31	35	34	38	45	45	49	49	50	58	59
Other Noncurrent Operating Liabilities	73	84	89	89	92	88	91	96	92	88	88
Total Equity & Noncontrolling Interests	1,350	1,475	1,440	1,429	1,411	1,426	1,351	1,360	1,359	1,351	1,260
Total Preferred & Common Equity	1,350	1,475	1,440	1,429	1,411	1,426	1,351	1,360	1,359	1,351	1,260
Preferred Stock	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Total Common Equity	1,350	1,475	1,440	1,429	1,411	1,426	1,351	1,360	1,359	1,351	1,260
Common Stock	1,181	1,188	1,198	1,206	1,215	1,224	1,235	1,245	1,257	1,261	1,269
Retained Earnings	230	344	400	502	555	609	716	767	818	922	976
Treasury Stock	-78	-78	-179	-295	-374	-417	-609	-659	-722	-836	-987
Accumulated Other Comprehensive Income / (Loss)	18	21	21	17	16	9.50	8.65	6.97	5.50	3.37	2.23

This table displays calculated financial ratios and metrics derived from Option Care Health's official financial filings.

Metric	2015	2016	2017	2018	2019	2020	2021	2022	2023	2024	2025
Period end date	12/31/2015	12/31/2016	12/31/2017	12/31/2018	12/31/2019	12/31/2020	12/31/2021	12/31/2022	12/31/2023	12/31/2024	12/31/2025
Growth Metrics	-	-	-	-	-	-	-	-	-	-	-
Revenue Growth	6.46%	-4.75%	95.39%	6.11%	19.11%	31.26%	13.39%	14.72%	9.07%	16.17%	13.03%
EBITDA Growth	-212.06%	113.36%	-18.03%	231.88%	-31.29%	231.43%	37.59%	29.02%	45.32%	-16.20%	2.56%
EBIT Growth	-152.50%	101.38%	-594.67%	313.32%	-120.29%	1,457.24%	78.87%	43.38%	58.96%	-19.23%	1.04%
NOPAT Growth	-152.50%	95.55%	348.24%	40.29%	-100.83%	34,819.44%	195.61%	-23.30%	33.25%	2.63%	3.15%
Net Income Growth	-103.52%	85.75%	109.07%	-257.68%	-1,141.54%	89.36%	1,832.27%	7.62%	77.40%	-20.69%	-2.00%
EPS Growth	-109.77%	87.80%	109.07%	-257.68%	-1,141.54%	91.84%	2,025.00%	7.79%	78.31%	-16.89%	3.25%
Operating Cash Flow Growth	-104.45%	33.77%	189.02%	-35.50%	61.56%	222.78%	63.72%	28.28%	38.78%	-12.90%	-20.08%
Free Cash Flow Firm Growth	74.01%	-283.21%	163.99%	-1,063.04%	-59.78%	115.97%	215.15%	-143.61%	211.55%	11.27%	-65.41%
Invested Capital Growth	-36.95%	24.51%	-9.69%	151.20%	92.28%	-4.02%	-13.94%	22.76%	-0.73%	-1.76%	7.22%
Revenue Q/Q Growth	4.13%	-0.39%	108.98%	-4.53%	-14.15%	2.85%	3.69%	2.60%	2.31%	4.65%	2.15%
EBITDA Q/Q Growth	28.10%	-47.31%	31.20%	-14.11%	-17.99%	16.60%	7.08%	6.01%	2.51%	0.43%	1.16%
EBIT Q/Q Growth	26.03%	-90.00%	4.29%	-20.89%	-153.34%	37.68%	11.75%	7.95%	2.90%	-0.02%	0.69%
NOPAT Q/Q Growth	26.03%	-132.19%	254.55%	-70.47%	-102.51%	37.78%	40.45%	-20.50%	5.13%	1.44%	0.38%
Net Income Q/Q Growth	12.98%	10.72%	105.11%	-115.38%	-90.47%	80.65%	70.05%	-15.65%	3.75%	1.42%	-0.78%
EPS Q/Q Growth	12.26%	24.66%	105.11%	-115.38%	-90.47%	96.75%	-48.32%	-21.70%	4.96%	2.50%	0.00%
Operating Cash Flow Q/Q Growth	3.12%	-17.70%	382.09%	-58.94%	37.04%	2.22%	23.47%	-7.55%	2.07%	-4.39%	-0.09%
Free Cash Flow Firm Q/Q Growth	23.56%	-111.61%	183.35%	-776.33%	39.42%	-1.83%	216.10%	-322.14%	-1.11%	-6.94%	5.51%
Invested Capital Q/Q Growth	-4.08%	1.34%	-1.13%	150.46%	-0.42%	0.75%	-13.32%	0.45%	1.13%	2.34%	1.99%
Profitability Metrics	-	-	-	-	-	-	-	-	-	-	-
Gross Margin	26.47%	28.01%	24.40%	21.77%	22.20%	22.50%	22.67%	21.98%	22.81%	20.27%	19.26%
EBITDA Margin	-22.47%	3.15%	1.32%	4.13%	2.39%	6.02%	7.31%	8.22%	10.95%	7.90%	7.17%
Operating Margin	-25.14%	-1.17%	1.49%	1.97%	-0.01%	3.65%	5.55%	6.09%	7.31%	6.44%	5.98%
EBIT Margin	-25.14%	0.37%	-0.92%	1.86%	-0.32%	3.27%	5.16%	6.45%	9.40%	6.54%	5.84%
Profit (Net Income) Margin	-30.56%	-4.57%	0.21%	-0.32%	-3.29%	-0.27%	4.07%	3.82%	6.21%	4.24%	3.67%
Tax Burden Percent	91.96%	125.20%	-26.37%	69.74%	97.09%	154.03%	120.09%	73.17%	74.45%	74.69%	73.38%
Interest Burden Percent	132.14%	-1,000.21%	87.06%	-24.33%	1,069.69%	-5.28%	65.64%	80.87%	88.70%	86.82%	85.71%
Effective Tax Rate	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	-20.09%	26.83%	25.55%	25.31%	26.62%
Return on Invested Capital (ROIC)	-34.15%	-1.75%	4.12%	3.47%	-0.01%	3.72%	12.07%	8.99%	10.90%	11.33%	11.38%
ROIC Less NNEP Spread (ROIC-NNEP)	-65.43%	-9.92%	0.70%	-3.49%	-8.80%	-3.91%	0.95%	5.25%	15.32%	7.30%	6.42%
Return on Net Nonoperating Assets (RNNOA)	-267.72%	-417.08%	17.60%	-5.50%	-10.04%	-4.56%	0.70%	2.77%	8.12%	3.66%	3.82%
Return on Equity (ROE)	-301.87%	-418.83%	21.72%	-2.04%	-10.06%	-0.84%	12.77%	11.75%	19.03%	14.99%	15.20%
Cash Return on Invested Capital (CROIC)	11.18%	-23.59%	14.30%	-82.64%	-63.16%	7.82%	27.05%	-11.45%	11.63%	13.10%	4.41%
Operating Return on Assets (OROA)	-36.44%	0.60%	-2.80%	3.55%	-0.36%	3.79%	6.53%	8.62%	12.78%	9.84%	9.60%
Return on Assets (ROA)	-44.29%	-7.53%	0.64%	-0.60%	-3.78%	-0.31%	5.14%	5.10%	8.44%	6.38%	6.04%
Return on Common Equity (ROCE)	-206.35%	2,348.37%	-72.00%	-1.76%	-10.06%	-0.84%	12.77%	11.75%	19.03%	14.99%	15.20%
Return on Equity Simple (ROE_SIMPLE)	371.09%	127.20%	-4.58%	-1.01%	-8.37%	-0.80%	11.90%	10.86%	18.79%	15.08%	0.00%
Net Operating Profit after Tax (NOPAT)	-173	-7.69	19	27	-0.22	78	229	176	234	240	248
NOPAT Margin	-17.60%	-0.82%	1.04%	1.38%	-0.01%	2.56%	6.66%	4.46%	5.44%	4.81%	4.39%
Net Nonoperating Expense Percent (NNEP)	31.28%	8.17%	3.41%	6.96%	8.79%	7.63%	11.12%	3.73%	-4.42%	4.03%	4.96%
Return On Investment Capital (ROIC_SIMPLE)	-	-	-	-	-	-	-	7.17%	9.43%	9.56%	9.97%
Cost of Revenue to Revenue	73.53%	74.83%	75.60%	78.23%	77.80%	77.50%	77.33%	78.02%	77.19%	79.73%	80.74%
SG&A Expenses to Revenue	21.16%	22.29%	18.51%	17.83%	19.89%	16.49%	15.29%	14.35%	14.12%	12.61%	12.08%
R&D to Revenue	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
Operating Expenses to Revenue	51.61%	26.34%	22.91%	19.79%	22.22%	18.85%	17.12%	15.89%	15.49%	13.83%	13.28%
Earnings before Interest and Taxes (EBIT)	-247	3.42	-17	36	-7.31	99	177	254	404	327	330
Earnings before Interest, Taxes, Depreciation and Amortization (EBITDA)	-221	29	24	80	55	183	251	324	471	395	405
Valuation Ratios	-	-	-	-	-	-	-	-	-	-	-
Price to Book Value (P/BV)	0.00	0.00	0.00	0.76	2.90	2.88	4.35	3.95	4.20	2.81	3.81
Price to Tangible Book Value (P/TBV)	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Price to Revenue (P/Rev)	0.12	0.13	0.20	0.24	1.14	0.96	1.49	1.39	1.39	0.79	0.90
Price to Earnings (P/E)	0.00	0.00	95.69	0.00	0.00	0.00	36.57	31.79	22.87	18.99	25.21
Dividend Yield	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
Earnings Yield	0.00%	0.00%	1.05%	0.00%	0.00%	0.00%	2.73%	3.15%	4.37%	5.27%	3.97%
Enterprise Value to Invested Capital (EV/IC)	1.50	1.31	2.02	0.87	1.81	1.93	3.45	2.90	3.12	2.21	2.65
Enterprise Value to Revenue (EV/Rev)	0.60	0.68	0.49	0.49	1.67	1.30	1.76	1.58	1.55	0.93	1.06
Enterprise Value to EBITDA (EV/EBITDA)	0.00	21.60	36.80	11.97	69.91	21.61	24.13	19.26	14.19	11.77	14.78
Enterprise Value to EBIT (EV/EBIT)	0.00	186.46	0.00	26.64	0.00	39.77	34.16	24.54	16.53	14.23	18.14
Enterprise Value to NOPAT (EV/NOPAT)	0.00	0.00	46.57	35.84	0.00	50.90	26.45	35.52	28.55	19.33	24.14
Enterprise Value to Operating Cash Flow (EV/OCF)	0.00	0.00	23.48	39.30	97.61	30.98	29.07	23.34	18.01	14.37	23.16
Enterprise Value to Free Cash Flow (EV/FCFF)	10.35	0.00	13.41	0.00	0.00	24.21	11.80	0.00	26.76	16.71	62.24
Leverage & Solvency	-	-	-	-	-	-	-	-	-	-	-
Debt to Equity	-23.28	11.77	-179.79	0.89	1.42	1.11	0.91	0.77	0.75	0.79	0.88
Long-Term Debt to Equity	-21.92	11.29	-179.15	0.89	1.41	1.10	0.90	0.76	0.74	0.79	0.87
Financial Leverage	4.09	42.04	24.98	1.58	1.14	1.17	0.73	0.53	0.53	0.50	0.60
Leverage Ratio	6.82	55.61	33.83	3.38	2.66	2.72	2.48	2.30	2.25	2.35	2.52
Compound Leverage Factor	9.01	-556.22	29.45	-0.82	28.47	-0.14	1.63	1.86	2.00	2.04	2.16
Debt to Total Capital	104.49%	92.17%	100.56%	47.22%	58.66%	52.54%	47.55%	43.43%	42.77%	44.17%	46.67%
Short-Term Debt to Total Capital	6.09%	3.78%	0.36%	0.36%	0.42%	0.43%	0.27%	0.24%	0.24%	0.26%	0.27%
Long-Term Debt to Total Capital	98.40%	88.39%	100.20%	46.86%	58.23%	52.11%	47.28%	43.19%	42.53%	43.92%	46.40%
Preferred Equity to Total Capital	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
Noncontrolling Interests to Total Capital	15.72%	14.68%	17.17%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
Common Equity to Total Capital	-20.21%	-6.86%	-17.73%	52.78%	41.34%	47.46%	52.45%	56.57%	57.23%	55.83%	53.33%
Debt to EBITDA	-1.89	15.33	19.89	6.73	23.35	6.16	4.24	3.28	2.26	2.81	2.87
Net Debt to EBITDA	-1.82	15.00	18.05	6.27	22.13	5.61	3.77	2.38	1.53	1.77	2.29
Long-Term Debt to EBITDA	-1.78	14.70	19.82	6.67	23.18	6.11	4.22	3.26	2.24	2.80	2.85
Debt to NOPAT	-2.42	-58.75	25.17	20.13	-5,761.29	14.50	4.65	6.05	4.54	4.62	4.68
Net Debt to NOPAT	-2.33	-57.51	22.84	18.78	-5,460.99	13.22	4.13	4.38	3.07	2.91	3.74
Long-Term Debt to NOPAT	-2.28	-56.34	25.08	19.98	-5,719.87	14.38	4.62	6.02	4.51	4.60	4.65
Altman Z-Score	-1.07	0.29	1.82	1.95	1.88	2.39	3.47	3.69	4.12	3.41	3.88
Noncontrolling Interest Sharing Ratio	31.64%	660.69%	431.50%	13.68%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
Liquidity Ratios	-	-	-	-	-	-	-	-	-	-	-
Current Ratio	1.20	1.33	1.77	1.95	1.69	1.51	1.55	1.76	1.77	1.70	1.53
Quick Ratio	0.74	0.91	1.19	1.44	1.19	0.99	1.00	1.19	1.17	1.05	0.85
Cash Flow Metrics	-	-	-	-	-	-	-	-	-	-	-
Free Cash Flow to Firm (FCFF)	57	-104	66	-639	-1,021	163	514	-224	250	278	96
Operating Cash Flow to CapEx	-532.76%	-747.25%	154.75%	92.97%	139.55%	474.02%	813.71%	1,293.25%	973.94%	908.25%	625.67%
Free Cash Flow to Firm to Interest Expense	0.71	0.00	0.00	-13.94	-13.84	1.51	7.67	-4.16	4.88	5.67	1.76
Operating Cash Flow to Interest Expense	-0.81	0.00	0.00	0.53	0.54	1.18	3.11	4.97	7.25	6.60	4.74
Operating Cash Flow Less CapEx to Interest Expense	-0.96	0.00	0.00	-0.04	0.15	0.93	2.73	4.59	6.50	5.87	3.98
Efficiency Ratios	-	-	-	-	-	-	-	-	-	-	-
Asset Turnover	1.45	1.65	3.03	1.91	1.15	1.16	1.26	1.34	1.36	1.51	1.64
Accounts Receivable Turnover	8.58	9.06	18.79	9.80	7.28	9.29	10.32	11.02	11.39	12.70	12.79
Inventory Turnover	18.01	17.69	37.25	25.00	18.04	17.13	15.56	15.11	13.33	12.04	10.62
Fixed Asset Turnover	28.02	28.96	61.29	32.30	20.42	23.85	29.56	35.88	37.58	40.31	42.38
Accounts Payable Turnover	9.36	10.81	21.20	11.96	8.79	9.33	9.46	9.35	8.25	7.68	7.30
Days Sales Outstanding (DSO)	42.55	40.27	19.43	37.23	50.13	39.28	35.38	33.12	32.03	28.75	28.53
Days Inventory Outstanding (DIO)	20.26	20.63	9.80	14.60	20.23	21.31	23.45	24.16	27.38	30.32	34.38
Days Payable Outstanding (DPO)	38.98	33.76	17.22	30.53	41.52	39.13	38.58	39.02	44.25	47.50	50.03
Cash Conversion Cycle (CCC)	23.83	27.14	12.01	21.30	28.83	21.46	20.25	18.25	15.17	11.57	12.88
Capital & Investment Metrics	-	-	-	-	-	-	-	-	-	-	-
Invested Capital	391	487	440	1,106	2,126	2,041	1,756	2,156	2,140	2,103	2,255
Invested Capital Turnover	1.94	2.13	3.94	2.51	1.43	1.46	1.81	2.02	2.00	2.36	2.59
Increase / (Decrease) in Invested Capital	-229	96	-47	666	1,020	-85	-284	400	-16	-38	152
Enterprise Value (EV)	586	637	889	960	3,852	3,946	6,062	6,243	6,686	4,647	5,985
Market Capitalization	120	122	371	457	2,633	2,921	5,116	5,473	5,968	3,948	5,057
Book Value per Share	($1.18)	($0.29)	($0.66)	$4.71	$1.28	$5.44	$6.54	$7.62	$8.03	$8.25	$8.36
Tangible Book Value per Share	($5.74)	($3.66)	($3.69)	($1.95)	($1.28)	($2.34)	($1.68)	($0.93)	($0.78)	($2.57)	($3.71)
Total Capital	400	490	478	1,142	2,193	2,140	2,242	2,450	2,484	2,515	2,487
Total Debt	418	452	481	539	1,286	1,124	1,066	1,064	1,063	1,111	1,161
Total Long-Term Debt	394	433	479	535	1,277	1,115	1,060	1,058	1,057	1,105	1,154
Net Debt	403	442	436	503	1,219	1,025	946	770	719	699	928
Capital Expenditures (CapEx)	12	5.69	24	26	28	27	26	21	38	36	41
Debt-free, Cash-free Net Working Capital (DFCFNWC)	40	52	39	195	171	133	137	141	138	136	210
Debt-free Net Working Capital (DFNWC)	55	62	83	232	238	232	257	435	482	549	442
Net Working Capital (NWC)	31	43	81	227	229	223	251	429	476	542	436
Net Nonoperating Expense (NNE)	127	35	15	33	76	86	89	25	-33	29	40
Net Nonoperating Obligations (NNO)	409	449	443	503	1,219	1,025	580	770	719	699	928
Total Depreciation and Amortization (D&A)	26	26	41	44	62	83	74	70	67	68	75
Debt-free, Cash-free Net Working Capital to Revenue	4.04%	5.57%	2.12%	10.06%	7.39%	4.38%	3.99%	3.57%	3.21%	2.73%	3.71%
Debt-free Net Working Capital to Revenue	5.63%	6.59%	4.55%	11.94%	10.30%	7.66%	7.46%	11.03%	11.20%	10.98%	7.83%
Net Working Capital to Revenue	3.15%	4.62%	4.46%	11.72%	9.90%	7.35%	7.29%	10.88%	11.06%	10.85%	7.71%
Earnings Adjustments	-	-	-	-	-	-	-	-	-	-	-
Adjusted Basic Earnings per Share	($18.04)	($2.16)	($2.40)	($1.96)	($0.49)	($0.04)	$0.78	$0.83	$1.49	$1.23	$1.28
Adjusted Weighted Average Basic Shares Outstanding	17.19M	30.25M	31.92M	32.04M	176.70M	179.81M	179.86M	181.11M	178.97M	171.57M	162.10M
Adjusted Diluted Earnings per Share	($18.04)	($2.16)	($2.40)	($1.96)	($0.49)	($0.04)	$0.77	$0.83	$1.48	$1.23	$1.27
Adjusted Weighted Average Diluted Shares Outstanding	17.19M	30.25M	31.92M	32.04M	176.70M	179.81M	181.21M	182.08M	180.38M	172.85M	163.37M
Adjusted Basic & Diluted Earnings per Share	($18.04)	($2.16)	($2.40)	($1.96)	($0.49)	($0.04)	$0.00	$0.00	$0.00	$0.00	$0.00
Adjusted Weighted Average Basic & Diluted Shares Outstanding	17.18M	23.44M	30.95M	31.99M	156.28M	180.97M	179.94M	181.96M	173.50M	165.32M	156.45M
Normalized Net Operating Profit after Tax (NOPAT)	21	3.41	19	27	-0.22	78	134	176	234	240	248
Normalized NOPAT Margin	2.09%	0.36%	1.04%	1.38%	-0.01%	2.56%	3.88%	4.46%	5.44%	4.81%	4.39%
Pre Tax Income Margin	-33.23%	-3.65%	-0.80%	-0.45%	-3.38%	-0.17%	3.39%	5.22%	8.34%	5.67%	5.01%
Debt Service Ratios	-	-	-	-	-	-	-	-	-	-	-
EBIT to Interest Expense	-3.11	0.00	0.00	0.79	-0.10	0.92	2.65	4.73	7.89	6.66	6.05
NOPAT to Interest Expense	-2.18	0.00	0.00	0.58	0.00	0.72	3.42	3.27	4.57	4.90	4.54
EBIT Less CapEx to Interest Expense	-3.26	0.00	0.00	0.21	-0.48	0.67	2.27	4.34	7.15	5.94	5.29
NOPAT Less CapEx to Interest Expense	-2.33	0.00	0.00	0.01	-0.39	0.47	3.04	2.88	3.83	4.18	3.79
Payout Ratios	-	-	-	-	-	-	-	-	-	-	-
Dividend Payout Ratio	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
Augmented Payout Ratio	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	93.70%	119.31%	149.31%

This table displays calculated financial ratios and metrics derived from Option Care Health's official financial filings.

Metric	Q4 2023	Q1 2024	Q2 2024	Q3 2024	Q4 2024	Q1 2025	Q2 2025	Q3 2025	Q4 2025	Q1 2026	Q2 2026
Period end date	12/31/2023	3/31/2024	6/30/2024	9/30/2024	12/31/2024	3/31/2025	6/30/2025	9/30/2025	12/31/2025	3/31/2026	6/30/2026
DEI Shares Outstanding	-	-	-	-	-	-	-	-	-	156,447,972.00	157,027,504.00
DEI Adjusted Shares Outstanding	-	-	-	-	-	-	-	-	-	156,447,972.00	157,027,504.00
DEI Earnings Per Adjusted Shares Outstanding	-	-	-	-	-	-	-	-	-	0.29	0.34
Growth Metrics	-	-	-	-	-	-	-	-	-	-	-
Revenue Growth	9.46%	12.82%	14.79%	16.97%	19.75%	16.31%	15.39%	12.24%	8.84%	1.33%	1.86%
EBITDA Growth	12.08%	3.06%	-45.70%	3.65%	1.56%	8.32%	0.12%	-1.75%	4.27%	-3.91%	5.34%
EBIT Growth	14.54%	3.61%	-50.25%	4.85%	-0.05%	8.73%	-1.59%	-4.23%	2.51%	-3.25%	5.36%
NOPAT Growth	22.44%	12.70%	-1.98%	-4.31%	5.42%	7.28%	2.16%	1.91%	1.70%	-7.41%	2.23%
Net Income Growth	20.30%	14.24%	-53.64%	-4.34%	5.17%	4.36%	-4.75%	-3.79%	-2.71%	-2.99%	6.71%
EPS Growth	26.92%	23.81%	-52.38%	0.00%	9.09%	7.69%	3.33%	3.23%	0.00%	3.57%	12.90%
Operating Cash Flow Growth	17.29%	-176.64%	15.41%	162.79%	-29.13%	89.51%	-53.83%	-13.07%	-0.64%	-67.87%	103.24%
Free Cash Flow Firm Growth	121.99%	-206.49%	-90.49%	30.66%	32.92%	108.76%	-717.76%	-174.43%	-184.23%	-73.79%	269.39%
Invested Capital Growth	-0.73%	29.05%	2.34%	-2.92%	-1.76%	0.80%	5.81%	7.58%	7.22%	1.90%	-2.04%
Revenue Q/Q Growth	2.87%	1.93%	7.08%	4.19%	5.31%	-1.00%	6.24%	1.34%	2.12%	-7.83%	6.79%
EBITDA Q/Q Growth	9.76%	-20.01%	16.90%	0.98%	7.56%	-14.69%	8.05%	-0.91%	14.15%	-21.38%	18.46%
EBIT Q/Q Growth	11.58%	-23.24%	20.58%	1.52%	6.36%	-16.50%	9.13%	-1.19%	13.84%	-21.19%	18.85%
NOPAT Q/Q Growth	-5.92%	-11.38%	9.42%	4.89%	3.65%	-9.81%	4.20%	4.63%	3.43%	-17.89%	15.05%
Net Income Q/Q Growth	1.55%	-21.66%	18.42%	1.53%	11.66%	-22.27%	8.09%	2.56%	12.91%	-22.50%	18.90%
EPS Q/Q Growth	6.45%	-21.21%	15.38%	3.33%	16.13%	-22.22%	10.71%	3.23%	12.50%	-19.44%	20.69%
Operating Cash Flow Q/Q Growth	-16.50%	-234.95%	384.45%	-18.02%	-77.48%	-119.97%	1,352.19%	54.36%	-74.26%	-133.74%	1,616.06%
Free Cash Flow Firm Q/Q Growth	-19.02%	-694.35%	102.27%	1,097.54%	-17.62%	-60.85%	-259.95%	-44.28%	6.77%	112.18%	933.86%
Invested Capital Q/Q Growth	1.13%	6.14%	-5.51%	-4.28%	2.34%	8.91%	-0.82%	-2.67%	1.99%	3.50%	-4.65%
Profitability Metrics	-	-	-	-	-	-	-	-	-	-	-
Gross Margin	21.98%	20.81%	20.32%	20.08%	19.93%	19.73%	19.00%	19.02%	19.30%	19.40%	18.53%
EBITDA Margin	9.50%	7.46%	8.14%	7.89%	8.06%	6.95%	7.06%	6.91%	7.72%	6.59%	7.31%
Operating Margin	7.52%	6.02%	6.57%	6.66%	6.46%	5.94%	5.84%	5.89%	6.24%	5.37%	5.90%
EBIT Margin	8.00%	6.02%	6.78%	6.61%	6.68%	5.63%	5.78%	5.64%	6.29%	5.38%	5.98%
Profit (Net Income) Margin	5.09%	3.91%	4.32%	4.21%	4.47%	3.51%	3.57%	3.61%	3.99%	3.36%	3.74%
Tax Burden Percent	72.44%	78.64%	73.63%	73.22%	74.19%	73.54%	73.37%	75.13%	71.77%	74.33%	72.87%
Interest Burden Percent	87.76%	82.51%	86.55%	87.04%	90.17%	84.68%	84.07%	85.21%	88.47%	84.01%	85.73%
Effective Tax Rate	27.56%	21.36%	26.37%	26.78%	25.81%	26.46%	26.63%	24.87%	28.23%	25.67%	27.13%
Return on Invested Capital (ROIC)	10.91%	10.41%	10.47%	11.16%	11.30%	9.93%	10.43%	11.47%	11.62%	9.79%	10.89%
ROIC Less NNEP Spread (ROIC-NNEP)	10.36%	8.90%	9.53%	9.86%	10.67%	8.64%	9.19%	9.90%	10.74%	8.89%	10.03%
Return on Net Nonoperating Assets (RNNOA)	5.49%	4.01%	4.48%	4.49%	5.35%	5.54%	5.46%	5.26%	6.40%	6.33%	7.18%
Return on Equity (ROE)	16.41%	14.43%	14.95%	15.65%	16.65%	15.47%	15.89%	16.73%	18.02%	16.11%	18.07%
Cash Return on Invested Capital (CROIC)	11.63%	-13.50%	8.98%	14.32%	13.10%	9.92%	5.48%	4.27%	4.41%	8.66%	12.96%
Operating Return on Assets (OROA)	10.87%	8.37%	9.34%	9.46%	10.05%	8.90%	9.24%	9.03%	10.33%	9.11%	10.08%
Return on Assets (ROA)	6.91%	5.43%	5.95%	6.03%	6.72%	5.55%	5.70%	5.78%	6.56%	5.69%	6.29%
Return on Common Equity (ROCE)	16.41%	14.43%	14.95%	15.65%	16.65%	15.47%	15.89%	16.73%	18.02%	16.11%	18.07%
Return on Equity Simple (ROE_SIMPLE)	0.00%	19.08%	14.97%	14.64%	0.00%	15.83%	0.00%	0.00%	0.00%	0.00%	0.00%
Net Operating Profit after Tax (NOPAT)	61	54	59	62	65	58	61	63	66	54	62
NOPAT Margin	5.45%	4.74%	4.84%	4.87%	4.80%	4.37%	4.29%	4.42%	4.48%	3.99%	4.30%
Net Nonoperating Expense Percent (NNEP)	0.55%	1.52%	0.94%	1.29%	0.63%	1.29%	1.23%	1.58%	0.88%	0.89%	0.87%
Return On Investment Capital (ROIC_SIMPLE)	2.47%	-	-	-	2.57%	2.37%	2.46%	2.52%	2.64%	2.15%	2.57%
Cost of Revenue to Revenue	78.02%	79.19%	79.68%	79.92%	80.07%	80.27%	81.00%	80.98%	80.70%	80.60%	81.47%
SG&A Expenses to Revenue	13.14%	13.50%	12.53%	12.28%	12.23%	12.61%	12.01%	11.99%	11.75%	12.92%	11.42%
R&D to Revenue	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
Operating Expenses to Revenue	14.46%	14.79%	13.75%	13.43%	13.47%	13.79%	13.16%	13.13%	13.06%	14.03%	12.63%
Earnings before Interest and Taxes (EBIT)	90	69	83	85	90	75	82	81	92	73	86
Earnings before Interest, Taxes, Depreciation and Amortization (EBITDA)	107	85	100	101	109	93	100	99	113	89	105
Valuation Ratios	-	-	-	-	-	-	-	-	-	-	-
Price to Book Value (P/BV)	4.20	4.16	3.41	3.75	2.81	4.28	3.91	3.32	3.81	3.12	2.61
Price to Tangible Book Value (P/TBV)	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Price to Revenue (P/Rev)	1.39	1.34	1.05	1.12	0.79	1.11	0.99	0.81	0.90	0.74	0.58
Price to Earnings (P/E)	22.87	21.79	22.78	26.41	18.99	28.06	26.25	21.95	25.21	20.96	16.08
Dividend Yield	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
Earnings Yield	4.37%	4.59%	4.39%	3.79%	5.27%	3.56%	3.81%	4.55%	3.97%	4.77%	6.22%
Enterprise Value to Invested Capital (EV/IC)	3.12	2.99	2.59	2.91	2.21	2.93	2.74	2.42	2.65	2.23	1.91
Enterprise Value to Revenue (EV/Rev)	1.55	1.53	1.21	1.25	0.93	1.30	1.16	0.97	1.06	0.92	0.75
Enterprise Value to EBITDA (EV/EBITDA)	14.19	14.32	14.25	15.22	11.77	16.71	15.50	13.38	14.78	12.94	10.47
Enterprise Value to EBIT (EV/EBIT)	16.53	16.67	17.19	18.31	14.23	20.19	18.80	16.34	18.14	15.85	12.83
Enterprise Value to NOPAT (EV/NOPAT)	28.55	28.37	23.16	25.24	19.33	27.47	25.34	21.69	24.14	21.32	17.38
Enterprise Value to Operating Cash Flow (EV/OCF)	18.01	31.88	23.23	17.68	14.37	17.45	22.28	20.71	23.16	20.49	12.28
Enterprise Value to Free Cash Flow (EV/FCFF)	26.76	0.00	29.11	20.02	16.71	29.68	51.42	58.78	62.24	25.94	14.61
Leverage & Solvency	-	-	-	-	-	-	-	-	-	-	-
Debt to Equity	0.75	0.74	0.79	0.78	0.79	0.82	0.82	0.86	0.88	0.86	0.92
Long-Term Debt to Equity	0.74	0.74	0.78	0.77	0.79	0.82	0.81	0.85	0.87	0.85	0.91
Financial Leverage	0.53	0.45	0.47	0.46	0.50	0.64	0.59	0.53	0.60	0.71	0.72
Leverage Ratio	2.25	2.30	2.31	2.33	2.35	2.36	2.43	2.48	2.52	2.48	2.58
Compound Leverage Factor	1.98	1.89	2.00	2.03	2.12	2.00	2.04	2.11	2.23	2.08	2.21
Debt to Total Capital	42.77%	42.64%	44.07%	43.80%	44.17%	45.12%	44.95%	46.10%	46.67%	46.19%	47.91%
Short-Term Debt to Total Capital	0.24%	0.24%	0.26%	0.26%	0.26%	0.26%	0.26%	0.27%	0.27%	0.27%	0.28%
Long-Term Debt to Total Capital	42.53%	42.40%	43.81%	43.55%	43.92%	44.86%	44.68%	45.83%	46.40%	45.92%	47.63%
Preferred Equity to Total Capital	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
Noncontrolling Interests to Total Capital	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
Common Equity to Total Capital	57.23%	57.36%	55.93%	56.20%	55.83%	54.88%	55.06%	53.90%	53.33%	53.81%	52.09%
Debt to EBITDA	2.26	2.24	2.85	2.83	2.81	2.76	2.76	2.90	2.87	2.89	2.85
Net Debt to EBITDA	1.53	1.78	1.89	1.60	1.77	2.34	2.27	2.13	2.29	2.45	2.37
Long-Term Debt to EBITDA	2.24	2.23	2.84	2.81	2.80	2.75	2.75	2.89	2.85	2.87	2.83
Debt to NOPAT	4.54	4.44	4.64	4.69	4.62	4.54	4.52	4.70	4.68	4.76	4.73
Net Debt to NOPAT	3.07	3.52	3.07	2.65	2.91	3.84	3.71	3.45	3.74	4.03	3.94
Long-Term Debt to NOPAT	4.51	4.42	4.61	4.66	4.60	4.51	4.49	4.68	4.65	4.73	4.70
Altman Z-Score	3.80	3.79	3.37	3.52	3.19	3.86	3.71	3.43	3.65	3.54	3.24
Noncontrolling Interest Sharing Ratio	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
Liquidity Ratios	-	-	-	-	-	-	-	-	-	-	-
Current Ratio	1.77	1.77	1.77	1.73	1.70	1.54	1.52	1.56	1.53	1.64	1.47
Quick Ratio	1.17	1.25	1.22	1.19	1.05	0.91	0.88	0.95	0.85	0.95	0.86
Cash Flow Metrics	-	-	-	-	-	-	-	-	-	-	-
Free Cash Flow to Firm (FCFF)	77	-457	10	124	102	40	-64	-92	-86	10	108
Operating Cash Flow to CapEx	256.32%	-1,181.86%	2,001.18%	1,658.90%	349.34%	-76.98%	993.22%	1,516.44%	263.01%	-133.87%	1,657.44%
Free Cash Flow to Firm to Interest Expense	6.19	-34.62	0.82	10.05	9.40	3.02	-4.43	-6.53	-6.76	0.79	7.73
Operating Cash Flow to Interest Expense	4.10	-5.21	15.52	12.99	3.32	-0.55	6.25	9.86	2.82	-0.91	13.10
Operating Cash Flow Less CapEx to Interest Expense	2.50	-5.65	14.75	12.21	2.37	-1.25	5.62	9.21	1.75	-1.59	12.31
Efficiency Ratios	-	-	-	-	-	-	-	-	-	-	-
Asset Turnover	1.36	1.39	1.38	1.43	1.51	1.58	1.60	1.60	1.64	1.69	1.68
Accounts Receivable Turnover	11.39	9.15	10.62	11.77	12.70	9.87	11.32	12.24	12.79	11.41	11.47
Inventory Turnover	13.33	14.00	13.23	13.47	12.04	13.58	12.60	12.27	10.62	11.67	11.48
Fixed Asset Turnover	37.58	39.13	39.80	40.84	40.31	41.11	41.72	42.51	42.38	41.79	41.55
Accounts Payable Turnover	8.25	7.37	7.18	7.41	7.68	8.18	7.67	7.31	7.30	8.53	7.49
Days Sales Outstanding (DSO)	32.03	39.89	34.38	31.02	28.75	36.97	32.25	29.81	28.53	31.98	31.82
Days Inventory Outstanding (DIO)	27.38	26.07	27.58	27.10	30.32	26.88	28.96	29.74	34.38	31.27	31.81
Days Payable Outstanding (DPO)	44.25	49.56	50.84	49.26	47.50	44.64	47.60	49.95	50.03	42.79	48.71
Cash Conversion Cycle (CCC)	15.17	16.40	11.12	8.86	11.57	19.21	13.60	9.61	12.88	20.46	14.92
Capital & Investment Metrics	-	-	-	-	-	-	-	-	-	-	-
Invested Capital	2,140	2,272	2,147	2,055	2,103	2,290	2,271	2,211	2,255	2,334	2,225
Invested Capital Turnover	2.00	2.20	2.16	2.29	2.36	2.27	2.43	2.59	2.59	2.45	2.53
Increase / (Decrease) in Invested Capital	-16	511	49	-62	-38	18	125	156	152	43	-46
Enterprise Value (EV)	6,686	6,784	5,550	5,982	4,647	6,717	6,230	5,357	5,985	5,194	4,258
Market Capitalization	5,968	5,941	4,815	5,353	3,948	5,778	5,319	4,505	5,057	4,212	3,293
Book Value per Share	$8.03	$8.22	$8.12	$8.34	$8.25	$8.17	$8.31	$8.37	$8.36	$8.64	$8.02
Tangible Book Value per Share	($0.78)	($2.52)	($2.57)	($2.48)	($2.57)	($3.58)	($1.65)	($3.49)	($3.71)	($3.55)	($4.06)
Total Capital	2,484	2,491	2,524	2,538	2,515	2,462	2,470	2,520	2,487	2,511	2,419
Total Debt	1,063	1,062	1,112	1,112	1,111	1,111	1,110	1,162	1,161	1,160	1,159
Total Long-Term Debt	1,057	1,056	1,106	1,105	1,105	1,104	1,104	1,155	1,154	1,153	1,152
Net Debt	719	843	735	629	699	939	911	852	928	982	965
Capital Expenditures (CapEx)	20	5.82	9.78	9.67	10	9.37	9.10	9.20	14	9.05	11
Debt-free, Cash-free Net Working Capital (DFCFNWC)	138	279	162	82	136	221	209	156	210	295	194
Debt-free Net Working Capital (DFNWC)	482	499	539	565	549	392	408	466	442	472	388
Net Working Capital (NWC)	476	493	532	558	542	386	402	459	436	465	381
Net Nonoperating Expense (NNE)	4.08	9.50	6.36	8.45	4.44	11	10	12	7.17	8.58	8.13
Net Nonoperating Obligations (NNO)	719	843	735	629	699	939	911	852	928	982	965
Total Depreciation and Amortization (D&A)	17	16	17	16	19	18	18	18	21	16	19
Debt-free, Cash-free Net Working Capital to Revenue	3.21%	6.30%	3.52%	1.71%	2.73%	4.26%	3.89%	2.82%	3.71%	5.20%	3.41%
Debt-free Net Working Capital to Revenue	11.20%	11.25%	11.73%	11.82%	10.98%	7.56%	7.59%	8.42%	7.83%	8.33%	6.81%
Net Working Capital to Revenue	11.06%	11.12%	11.59%	11.69%	10.85%	7.44%	7.47%	8.30%	7.71%	8.21%	6.69%
Earnings Adjustments	-	-	-	-	-	-	-	-	-	-	-
Adjusted Basic Earnings per Share	$0.32	$0.26	$0.31	$0.32	$0.34	$0.28	$0.31	$0.32	$0.37	$0.29	$0.35
Adjusted Weighted Average Basic Shares Outstanding	178.97M	173.93M	172.93M	170.64M	171.57M	165.46M	162.93M	161.83M	162.10M	156.65M	152.93M
Adjusted Diluted Earnings per Share	$0.33	$0.26	$0.30	$0.31	$0.36	$0.28	$0.31	$0.32	$0.36	$0.29	$0.35
Adjusted Weighted Average Diluted Shares Outstanding	180.38M	175.62M	174.09M	171.94M	172.85M	166.80M	164.13M	163.09M	163.37M	158.21M	153.49M
Adjusted Basic & Diluted Earnings per Share	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00
Adjusted Weighted Average Basic & Diluted Shares Outstanding	173.50M	173.82M	171.02M	170.18M	165.32M	163.75M	162.30M	158.73M	156.45M	157.03M	149.79M
Normalized Net Operating Profit after Tax (NOPAT)	61	54	59	62	65	58	61	63	66	54	62
Normalized NOPAT Margin	5.45%	4.74%	4.84%	4.87%	4.80%	4.37%	4.29%	4.42%	4.48%	3.99%	4.30%
Pre Tax Income Margin	7.02%	4.97%	5.87%	5.75%	6.02%	4.77%	4.86%	4.81%	5.56%	4.52%	5.13%
Debt Service Ratios	-	-	-	-	-	-	-	-	-	-	-
EBIT to Interest Expense	7.23	5.23	6.60	6.85	8.26	5.67	5.67	5.72	7.24	5.46	6.16
NOPAT to Interest Expense	4.93	4.11	4.71	5.05	5.94	4.40	4.20	4.49	5.16	4.05	4.43
EBIT Less CapEx to Interest Expense	5.63	4.79	5.83	6.06	7.31	4.96	5.04	5.07	6.16	4.78	5.37
NOPAT Less CapEx to Interest Expense	3.33	3.67	3.94	4.26	4.99	3.69	3.57	3.84	4.09	3.37	3.64
Payout Ratios	-	-	-	-	-	-	-	-	-	-	-
Dividend Payout Ratio	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
Augmented Payout Ratio	93.70%	78.96%	138.84%	112.64%	119.31%	0.00%	135.87%	146.97%	149.31%	0.00%	156.54%

Financials Breakdown Chart

Key Financial Trends

Option Care Health (NASDAQ: OPCH) opened 2026 with a much weaker cash flow profile than it showed a year earlier, even though revenue and net income remained solid. The company continues to grow sales, but the quarter also showed pressure from working capital, elevated liabilities, and a sharp drop in operating cash flow.

Revenue and earnings trends remain positive, but growth has slowed. Q1 2026 revenue rose to $1.35 billion from $1.33 billion in Q1 2025, a modest increase. Gross profit also improved to $262.0 million from $263.1 million a year ago, while operating income increased slightly to $72.5 million from $79.2 million in Q1 2025. Net income attributable to common shareholders came in at $44.6 million, down from $44.3 million in the prior-year quarter, so profitability held up, but not by much.

The biggest concern is cash generation. In Q1 2026, Option Care reported negative operating cash flow of $12.1 million, compared with positive $35.9 million in Q4 2025 and negative $7.2 million in Q1 2025. The main culprit was a large working-capital drag of $81.6 million, which overwhelmed earnings and non-cash add-backs. That is a clear sign that accounting profits are not currently turning into cash efficiently.

The balance sheet remains highly leveraged. As of March 31, 2026, OPCH carried $1.15 billion of long-term debt and $1.30 billion of total liabilities, against $1.35 billion of equity. Cash and equivalents were $177.3 million, down from $309.8 million at Q3 2025 and $198.8 million at Q2 2025. The company still has liquidity, but the cash balance has been trending lower.

Working capital remains a mixed picture. Accounts receivable rose to $516.4 million, inventories were $415.7 million, and accounts payable were $545.0 million. Those are sizable operating balances for a healthcare distributor, and they help explain why cash flow can swing sharply quarter to quarter.

Shareholder returns have been supported by buybacks, but repurchases have also added to cash usage. In Q1 2026, debt repayment was modest at $3.7 million, while the company still had $30.1 million of other financing outflows. In earlier quarters, OPCH used far more cash for repurchases, including $95.1 million in Q4 2025 and $62.5 million in Q3 2025.

Revenue continued to grow year over year in Q1 2026, showing the core business is still expanding.
Net income remained positive at $45.3 million, indicating the company is still profitable.
Operating income was still solid at $72.5 million, despite pressure from costs and other expenses.
Inventory and receivables-backed business model continues to support a large scale operating base.
Debt levels remain manageable relative to equity, but leverage is still high at $1.15 billion long-term debt.
Cash balance is still meaningful, though it declined notably from recent quarters.
SG&A stayed fairly stable versus the prior year, suggesting some operating discipline.
Operating cash flow turned negative in Q1 2026, a major red flag for near-term financial flexibility.
Working capital was a major drain on cash, with an $81.6 million negative impact in the quarter.
The company remains heavily leveraged and dependent on continued earnings and cash generation to service debt.

Longer term, the trend is still constructive on the income statement but choppy on the cash flow statement. Over the last four years, OPCH has grown revenue from about $1.02 billion in Q1 2023 to $1.35 billion in Q1 2026. Earnings have generally stayed profitable, but quarterly cash flow has been volatile, with some periods of strong operating cash generation followed by sharp pullbacks. For investors, that means the stock’s story still depends on whether management can convert its earnings power into steadier free cash flow while keeping leverage under control.

08/02/26 06:53 AM ETAI Generated. May Contain Errors.

Option Care Health Financials - Frequently Asked Questions

According to the most recent income statement we have on file, Option Care Health's financial year ends in December. Their financial year 2025 ended on December 31, 2025.

Option Care Health's net income appears to be on an upward trend, with a most recent value of $207.59 million in 2025, falling from -$300.13 million in 2015. The previous period was $211.82 million in 2024. View Option Care Health's forecast to see where analysts expect Option Care Health to go next.

Option Care Health's total operating income in 2025 was $337.91 million, based on the following breakdown:

Total Gross Profit: $1.09 billion
Total Operating Expenses: $749.99 million

Over the last 10 years, Option Care Health's total revenue changed from $982.22 million in 2015 to $5.65 billion in 2025, a change of 475.2%.

Option Care Health's total liabilities were at $2.13 billion at the end of 2025, a 5.5% increase from 2024, and a 288.1% increase since 2015.

In the past 10 years, Option Care Health's cash and equivalents has ranged from $9.57 million in 2016 to $412.57 million in 2024, and is currently $232.62 million as of their latest financial filing in 2025.

Over the last 10 years, Option Care Health's book value per share changed from -1.18 in 2015 to 8.36 in 2025, a change of -810.3%.

Related Companies

Financial statements for NASDAQ:OPCH last updated on 7/29/2026 by MarketBeat.com Staff. New filings and market data are monitored continuously.

From Our Partners

Unlock superior investment research and tools.

Get MarketBeat All Access

In-depth profiles and analysis for 20,000 public companies.
Real-time analyst ratings, insider transactions, earnings data, and more.
Our daily ratings and market update email newsletter.

Sign In
Create Account

Your Email Address:

Your Password:

Forgot your password?

Your Email Address:

Choose a Password:

By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Option Care Health (OPCH) Financials

Financials Breakdown Chart

Key Financial Trends

Option Care Health Financials - Frequently Asked Questions

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools

About MarketBeat

MarketBeat Products

Popular Tools

Financial Calendars

Terms & Info

Option Care Health (OPCH) Financials

Annual Income Statements for Option Care Health

Quarterly Income Statements for Option Care Health

Annual Cash Flow Statements for Option Care Health

Quarterly Cash Flow Statements for Option Care Health

Annual Balance Sheets for Option Care Health

Quarterly Balance Sheets for Option Care Health

Annual Metrics And Ratios for Option Care Health

Quarterly Metrics And Ratios for Option Care Health

Financials Breakdown Chart

Key Financial Trends

Option Care Health Financials - Frequently Asked Questions

When does Option Care Health's fiscal year end?

How has Option Care Health's net income changed over the last 10 years?

What is Option Care Health's operating income?

How has Option Care Health's revenue changed over the last 10 years?

How much debt does Option Care Health have?

How much cash does Option Care Health have?

How has Option Care Health's book value per share changed over the last 10 years?

MarketBeat All Access Features

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools